Galactooligosaccharides and 2′-fucosyllactose can directly suppress growth of specific pathogenic microbes and affect phagocytosis of neutrophils
Author(s)
Mortaz, Esmaeil
Nomani, Masoumeh
Adcock, Ian
Folkerts, Gert
Garssen, Johan
Type
Journal Article
Abstract
Objectives
Non-digestible oligosaccharides such as milk oligosaccharides (MOS) can regulate and influence immune function. As an example, galactooligosaccharides (GOS), and 2′-fucosyllactose (2′-FL; a specific human MOS) regulate immune development and functionality. Staphylococcus aureus (SA) and Pseudomonas aeruginosa (PA), both serious pathogens, can cause severe and life-threatening infections. The aim of this study was to examine the effects of GOS and 2′-FL on bacterial growth and on polymorphonuclear (PMN) phagocytosis.
Methods
PMNs were isolated from heparinized whole human blood before treatment/incubation with GOS (0.0625–10%), 2′-FL (0.5–2.5%) and/or GOS combined with 2′-FL (GOS 10%/2′-FL 2.5%; GOS 0.0625%/2′-FL 0.5%) and incubation with green florescent protein (GFP)-labeled SA or PA for 60 h. GFP-relative fluorescent units (GFP-RFU) was measured ≤60 h using a plate reader. Bacterial lag time was determined by the time to onset of exponential bacterial fluorescence/growth alone or after co-culture of bacteria and PMN. Viable bacterial colony-forming units (CFUs) were determined after 60 h.
Results
SA and PA growth lag time was suppressed by co-incubation with GOS in a concentration-dependent manner. This was significant for both SA and PA at concentrations >2.5% GOS (P ≤ 0.05 for both SA and PA) but only for SA at 1% GOS (P ≤ 0.05). 1.5% 2′-FL significantly suppressed the lag time of SA growth (P ≤ 0.05) and was effective against SA and PA at 2.5% (P ≤ 0.01 and P ≤ 0.01, respectively). GOS (10%, 5%) and 2.5% 2′-FL significantly decreased SA and PA bacterial growth/CFUs (P ≤ 0.05).
Conclusion
The data suggests that both GOS and 2′-FL can suppress growth of serious pathogens and enhance phagocytosis.
Non-digestible oligosaccharides such as milk oligosaccharides (MOS) can regulate and influence immune function. As an example, galactooligosaccharides (GOS), and 2′-fucosyllactose (2′-FL; a specific human MOS) regulate immune development and functionality. Staphylococcus aureus (SA) and Pseudomonas aeruginosa (PA), both serious pathogens, can cause severe and life-threatening infections. The aim of this study was to examine the effects of GOS and 2′-FL on bacterial growth and on polymorphonuclear (PMN) phagocytosis.
Methods
PMNs were isolated from heparinized whole human blood before treatment/incubation with GOS (0.0625–10%), 2′-FL (0.5–2.5%) and/or GOS combined with 2′-FL (GOS 10%/2′-FL 2.5%; GOS 0.0625%/2′-FL 0.5%) and incubation with green florescent protein (GFP)-labeled SA or PA for 60 h. GFP-relative fluorescent units (GFP-RFU) was measured ≤60 h using a plate reader. Bacterial lag time was determined by the time to onset of exponential bacterial fluorescence/growth alone or after co-culture of bacteria and PMN. Viable bacterial colony-forming units (CFUs) were determined after 60 h.
Results
SA and PA growth lag time was suppressed by co-incubation with GOS in a concentration-dependent manner. This was significant for both SA and PA at concentrations >2.5% GOS (P ≤ 0.05 for both SA and PA) but only for SA at 1% GOS (P ≤ 0.05). 1.5% 2′-FL significantly suppressed the lag time of SA growth (P ≤ 0.05) and was effective against SA and PA at 2.5% (P ≤ 0.01 and P ≤ 0.01, respectively). GOS (10%, 5%) and 2.5% 2′-FL significantly decreased SA and PA bacterial growth/CFUs (P ≤ 0.05).
Conclusion
The data suggests that both GOS and 2′-FL can suppress growth of serious pathogens and enhance phagocytosis.
Date Issued
2022-04
Date Acceptance
2022-01-09
Citation
Nutrition, 2022, 96
ISSN
0899-9007
Publisher
Elsevier BV
Journal / Book Title
Nutrition
Volume
96
Copyright Statement
© 2022 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/)
(http://creativecommons.org/licenses/by-nc-nd/4.0/)
Identifier
https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000820244600022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
Subjects
2 '-fucosyllactose
Colony-forming units
DIETARY MODULATION
ESCHERICHIA-COLI
GALACTO-OLIGOSACCHARIDES
GOS
HUMAN COLONIC MICROBIOTA
IN-VITRO
Lag time
Life Sciences & Biomedicine
Non-digestible oligosaccharides
Nutrition & Dietetics
PREBIOTICS
PROBIOTICS
Pseudomonas aeruginosa
Science & Technology
Staphylococcus aureus
Publication Status
Published
Article Number
111601
Date Publish Online
2022-01-19